Press release
Antifibrinolytic Drugs Market Size, Share, Trends, Global Demand, Growth, Opportunities and Forecast 2022-2027
The latest research study "Antifibrinolytic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global antifibrinolytic drugs market reached a value of US$ 15.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 20.46 Billion by 2027, exhibiting a CAGR of 4.60% during 2022-2027.Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download free sample brochure: https://www.imarcgroup.com/antifibrinolytic-drugs-market/requestsample
Industry Definition and Application:
Antifibrinolytic drugs are medicines used for promoting the formation of blood clots to prevent fibrinolysis or blockage in arteries and veins. They restrict the breakdown of fibrin to treat hemorrhage, coagulation disorders, and vascular tumors. These drugs are also used to control the bleeding during or after intrusive surgeries and manage mucosal bleeding in the nose, gastrointestinal (GI) tract, oropharynx, and uterine-vaginal linings. As a result, antifibrinolytic drugs are widely adopted across clinics, hospitals, and ambulatory surgical centers.
Global Antifibrinolytic Drugs Market Trends and Drivers:
The market is primarily driven by the rising incidence of road accidents, trauma, and several bleeding disorders. In addition, the increasing product adoption to prevent blood loss in women suffering from menorrhagia and during cardiovascular and neuro surgeries represents another major growth-inducing factor. Moreover, the market is further propelled by the growing awareness among the masses regarding the available treatment options for genetic angioedema and hemophilia.
Besides this, various technological advancements and the increasing utilization of antifibrinolytic therapy to reduce transfusion in orthopedic patients are accelerating the drug adoption rate. Moreover, other factors, including the rising geriatric population, the introduction of innovative drug variants with improved effectiveness and bio-absorbability, and significant improvements in the healthcare infrastructure, are anticipated to propel market growth in the coming years.
Global Antifibrinolytic Drugs Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
ACIC Pharmaceuticals Inc., Akorn Inc., Aurobindo Pharma Limited, Ferring Pharmaceuticals, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Viatris Inc. and Vitruvias Therapeutics Inc.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/antifibrinolytic-drugs-market
The report has segmented the market on the basis of region, indication, form and end user.
Breakup by Indication:
• Gynecology
• Hereditary Angioedema
• Fibrinolytic Response Testing
• Surgeries
• Others
Breakup by Form:
• Oral
• Injectable
Breakup by End User:
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Trauma Centers
• Others
Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Browse Other Related Reports by IMARC Group:
Electric Vehicle Range Extender Market Report: https://www.imarcgroup.com/electric-vehicle-range-extender-market
Premise Cable Market Report: https://www.imarcgroup.com/premise-cable-market
Collaborative Robot Market Report: https://www.imarcgroup.com/collaborative-robot-market
Plastic Contract Manufacturing Market Report: https://www.imarcgroup.com/plastic-contract-manufacturing-market
Coffee Pods and Capsules Market Report: https://www.imarcgroup.com/coffee-pods-capsules-market
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antifibrinolytic Drugs Market Size, Share, Trends, Global Demand, Growth, Opportunities and Forecast 2022-2027 here
News-ID: 2712007 • Views: …
More Releases from IMARC Group
EV Charging Station Manufacturing Plant Setup 2025: Project Cost, Requirements & …
Introduction
Electric vehicle (EV) charging stations are specialized facilities designed to supply electric energy for the recharging of electric vehicles. These stations vary from slow chargers suitable for home or workplace use to fast and ultra-fast chargers that enable rapid charging in public spaces. With the global shift toward sustainable mobility, EV charging stations play a crucial role in supporting the adoption of electric vehicles by addressing range anxiety and providing…
Liquefied Natural Gas (LNG) Manufacturing Plant: Setup Cost, Capital Investment …
Introduction
Liquefied Natural Gas (LNG) is natural gas, primarily methane, that has been cooled to around -162°C (-260°F) to convert it into a liquid form for easier storage and transportation. This process reduces its volume by approximately 600 times, making it economically viable to transport over long distances where pipelines are not feasible. LNG is colorless, odorless, and non-toxic, and it serves as a cleaner alternative to other fossil fuels due…
US Landscaping Service Market Size, Trends, Growth and Forecast 2026-2034
IMARC Group has recently released a new research study titled "US Landscaping Service Market Size, Share, Trends and Forecast by Type, End Use, and Region, 2026-2034", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
Market Overview
The US landscaping service market reached a market size of USD 86,862.28 Million in 2025 and is expected to grow to…
Latin America Legal Tech Market to Reach USD 4.8 Billion by 2033, AI Research To …
Market Overview
The Latin America legal tech market size was USD 1.7 Billion in 2024. The market is expected to reach USD 4.8 Billion by 2033, growing at a CAGR of 11.12% during the forecast period of 2025 to 2033. Growth is driven by rapid digital transformation, demand for remote legal solutions, enhanced data security, and adoption of AI technologies that aid in case outcome analysis and data-driven client insights. This…
More Releases for Antifibrinolytic
Antifibrinolytic Drugs Market | Pipeline Advancements & Clinical Trials Boost Ma …
DataM Intelligence unveils its latest report on the "Antifibrinolytic Drugs Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming…
Increasing Road Accidents Fuel Growth in Antifibrinolytic Drug Market: A Signifi …
The Antifibrinolytic Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Antifibrinolytic Drugs Market Size and Projected Growth Rate?
Over the past few years, there has been robust growth in the size of the antifibrinolytic drugs market. The growth from $16.82 billion in…
Antifibrinolytic Drugs Market Expected to Reach $19,333 Million by 2026 | Top Re …
According to a new report published by Allied Market Research, titled, "Antifibrinolytic Drugs Market by Indication and End User: Global opportunity analysis and industry forecast, 2019-2026," the global antifibrinolytic drugs market size is expected to reach $19,333 million by 2026, registering a CAGR of 4.5% from 2019 to 2026, in terms of value.
Antifibrinolytics are one of the most commonly used drugs to prevent fibrinolysis by blocking the activation of plasminogen…
Leading Growth Driver in the Antifibrinolytic Drugs Market in 2025: Increasing R …
What market dynamics are playing a key role in accelerating the growth of the antifibrinolytic drugs market?
The escalating rate of road mishaps projects an upward trajectory for the antifibrinolytic drugs market. Causes for this surge in road accidents range from smartphone usage, excessive speed, driving while intoxicated, and poor vehicle upkeep. Antifibrinolytic medications have a critical role in managing hemorrhage in victims of road crashes by consolidating blood clots, curtailing…
Leading Growth Driver in the Antifibrinolytic Drugs Market in 2025: Increasing R …
What Are the Market Size and Growth Forecast for the Antifibrinolytic Drugs Market?
In the past few years, there has been a significant expansion in the size of the antifibrinolytic drugs market. The market, which was valued at $16.82 billion in 2024, is projected to rise to $17.84 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%. The surge in this market over the historical period is largely…
Antifibrinolytic Drugs Market Opportunities and Forecasts, 2017 – 2025
Hemostatic agents prevent the blood loss and have the different site of action in complex coagulation and fibrinolysis pathways. Antifibrinolytic drugs inhibit the activation of plasminogen to plasmin preventing the lysis of fibrin and maintaining the clot stability. These Antifibrinolytic drugs prevent excessive bleeding. Tranexamic acid is used when the risk of hemorrhage is high because of increased fibrinolysis. Aprotinin, a proteolytic enzyme inhibitor which acts on plasmin and kallikrein.…
